Burden of Chronic obstructive pulmonary disease in China: an analysis based on the GBD 2021 compared with the United States
The burden of COPD will not rapidly decline in the short term, both China and the US, as well as the global community, must take this disease seriously.
Authors
- Wei Gao (ORCID: https://orcid.org/0000-0003-2880-154X)
- Yu Li (ORCID: https://orcid.org/0000-0003-4798-1638)
- Rong Li (ORCID: https://orcid.org/0009-0008-6177-2246)
- Chan Xiong
Institutions
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1371/journal.pone.0321470
- Citations
- 3
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Sichuan Provincial Administration of Traditional Chinese Medicine
- Sichuan Province Science and Technology Support Program